{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T19:32:54Z","timestamp":1786649574406,"version":"build-2736575974"},"reference-count":28,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,1]]},"abstract":"\n Background:<\/jats:title>\n Non-albuminuric diabetic kidney disease (NADKD) is increasingly recognised and strongly associated with heightened cardiovascular risk and rapid decline in estimated glomerular filtration rate (eGFR).<\/jats:p>\n <\/jats:sec>\n \n Aims:<\/jats:title>\n This single-centre retrospective cohort study aimed to determine the prevalence of NADKD, characterise clinical and laboratory features, assess microvascular and macrovascular complication rates and identify predictors of rapid progression.<\/jats:p>\n <\/jats:sec>\n \n Materials and Methods:<\/jats:title>\n \n This retrospective cohort study analysed 44 NADKD patients from January 2018 to 2022, excluding chronic kidney disease stage 5, albuminuric DKD and <6 months of follow-up. The primary outcome was the prevalence and profile of rapid progressors (eGFR fall of >5 mL\/min\/1.73 m\n 2<\/jats:sup>\n \/year) in NADKD and secondary outcomes were the onset of microvascular and macrovascular complications and risk factors for rapid progression.\n <\/jats:p>\n <\/jats:sec>\n \n Results:<\/jats:title>\n \n The median 1-year follow-up showed rapid eGFR drop in 36.4% of patients, with a median yearly decline of 8.0 mL\/min\/1.73 m\n 2<\/jats:sup>\n \/year (Interquartile range [IQR]: 6.2\u201312.1) compared to 1.0 mL\/min\/1.73 m\n 2<\/jats:sup>\n \/year (IQR: 0.5\u20131.8) in non-progressors (\n P<\/jats:italic>\n < 0.001). Presence of hypertension (\n P<\/jats:italic>\n = 0.04), cardiovascular disease (CVD) (\n P<\/jats:italic>\n = 0.03), dyslipidaemia (\n P<\/jats:italic>\n = 0.02) and acute kidney injury (AKI) incidents (\n P<\/jats:italic>\n = 0.01), as well as the incidence of diabetic retinopathy (\n P<\/jats:italic>\n = 0.01) and CVD (\n P<\/jats:italic>\n = 0.04), were reported to be higher in rapid progressors. Rapid eGFR reduction was independently predicted by hypertension (Odds ratio [OR] 1.9, 95% confidence interval [CI]: 1.5\u20134.8), CVD (OR 2.8, 95% CI: 1.8\u20134.7,\n P<\/jats:italic>\n = 0.01) in multivariate analysis.\n <\/jats:p>\n <\/jats:sec>\n \n Conclusion:<\/jats:title>\n One-third of NADKD were rapid progressors, and the prevalence of hypertension, dyslipidaemia, CVD, AKI episodes and incidence of diabetic retinopathy was higher in rapid progressors. Hypertension and CVD were found to be strong predictors for rapid eGFR decline.<\/jats:p>\n <\/jats:sec>","DOI":"10.4103\/npmj.npmj_341_25","type":"journal-article","created":{"date-parts":[[2026,1,2]],"date-time":"2026-01-02T07:00:14Z","timestamp":1767337214000},"page":"38-43","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":1,"title":["Prevalence and Predictors of Rapid Estimated Glomerular Filtration Rate Decline in Patients with Non-albuminuric Diabetic Kidney Disease: A Single-centre Retrospective Cohort Study"],"prefix":"10.4103","volume":"33","author":[{"given":"Priya","family":"Rani","sequence":"first","affiliation":[{"name":"Department of Nephrology, Kasturba Medical College, Manipal, Manipal Academy of Higher Education, Manipal, Karnataka, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shankar Prasad","family":"Nagaraju","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Kasturba Medical College, Manipal, Manipal Academy of Higher Education, Manipal, Karnataka, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shilna Muttickal","family":"Swaminathan","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Kasturba Medical College, Manipal, Manipal Academy of Higher Education, Manipal, Karnataka, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohan Varadanayakanahalli","family":"Bhojaraja","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Kasturba Medical College, Manipal, Manipal Academy of Higher Education, Manipal, Karnataka, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Attur Ravindra","family":"Prabhu","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Kasturba Medical College, Manipal, Manipal Academy of Higher Education, Manipal, Karnataka, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dharshan","family":"Rangaswamy","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Kasturba Medical College, Manipal, Manipal Academy of Higher Education, Manipal, Karnataka, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Indu Ramachandra","family":"Rao","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Kasturba Medical College, Manipal, Manipal Academy of Higher Education, Manipal, Karnataka, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Srinivas Vinayak","family":"Shenoy","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Kasturba Medical College, Manipal, Manipal Academy of Higher Education, Manipal, Karnataka, India"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2026,1,2]]},"reference":[{"key":"R1-20260420","doi-asserted-by":"crossref","first-page":"871272","DOI":"10.3389\/fendo.2022.871272","article-title":"Comparison of nonalbuminuric and albuminuric diabetic kidney disease among patients with type 2 diabetes: A systematic review and meta-analysis","volume":"13","author":"Shi","year":"2022","journal-title":"Front Endocrinol (Lausanne)"},{"key":"R2-20260420","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1007\/s11684-017-0542-7","article-title":"Normoalbuminuric diabetic kidney disease","volume":"11","author":"Chen","year":"2017","journal-title":"Front Med"},{"key":"R3-20260420","doi-asserted-by":"crossref","first-page":"10222","DOI":"10.3390\/ijms251810222","article-title":"Novel insights into diabetic kidney disease","volume":"25","author":"M\u0142ynarska","year":"2024","journal-title":"Int J Mol Sci"},{"key":"R4-20260420","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1111\/joim.20060","article-title":"Diagnosis and treatment of chronic kidney diseases and type 2 diabetes mellitus: A paradigm shift for enhancing cardiovascular prognosis","volume":"297","author":"Jankowski","year":"2025","journal-title":"J Intern Med"},{"key":"R5-20260420","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.2337\/dc08-2186","article-title":"Nonalbuminuric renal impairment in type 2 diabetic patients and in the general population (national evaluation of the frequency of renal impairment cO-existing with NIDDM [NEFRON] 11)","volume":"32","author":"Thomas","year":"2009","journal-title":"Diabetes Care"},{"key":"R6-20260420","doi-asserted-by":"crossref","first-page":"1832","DOI":"10.2337\/db05-1620","article-title":"Risk factors for renal dysfunction in type 2 diabetes: U.K. Prospective diabetes study 74","volume":"55","author":"Retnakaran","year":"2006","journal-title":"Diabetes"},{"key":"R7-20260420","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1093\/ndt\/gfn603","article-title":"Prevalence of albuminuria and renal insufficiency and associated clinical factors in type 2 diabetes: The Japan Diabetes Clinical Data Management study (JDDM15)","volume":"24","author":"Yokoyama","year":"2009","journal-title":"Nephrol Dial Transplant"},{"key":"R8-20260420","doi-asserted-by":"crossref","first-page":"S75","DOI":"10.3346\/jkms.2009.24.S1.S75","article-title":"The clinical characteristics of normoalbuminuric renal insufficiency in Korean type 2 diabetic patients: A possible early stage renal complication","volume":"24","author":"An","year":"2009","journal-title":"J Korean Med Sci"},{"key":"R9-20260420","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1111\/1753-0407.13230","article-title":"A study on the status of normoalbuminuric renal insufficiency among type 2 diabetes mellitus patients: A multicenter study based on a Chinese population","volume":"14","author":"Jia","year":"2022","journal-title":"J Diabetes"},{"key":"R10-20260420","doi-asserted-by":"crossref","first-page":"102","DOI":"10.17925\/EE.2022.18.2.102","article-title":"Non-albuminuric diabetic kidney disease phenotype: Beyond albuminuria","volume":"18","author":"D\u2019Marco","year":"2022","journal-title":"touchREV Endocrinol"},{"key":"R11-20260420","doi-asserted-by":"crossref","first-page":"283","DOI":"10.4103\/ijn.ijn_54_22","article-title":"Clinical profile of nonproteinuric kidney disease in type 2 diabetic patients in India","volume":"33","author":"Sangha","year":"2023","journal-title":"Indian J Nephrol"},{"key":"R12-20260420","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1038\/ki.2013.444","article-title":"Summary of KDIGO 2012 CKD guideline: Behind the scenes, need for guidance, and a framework for moving forward","volume":"85","author":"Levin","year":"2014","journal-title":"Kidney Int"},{"issue":"Suppl 2","key":"R13-20260420","doi-asserted-by":"crossref","first-page":"S777","DOI":"10.1016\/j.dsx.2017.05.016","article-title":"Non-proteinuric diabetic nephropathy is the main cause of chronic kidney disease: Results of a general population survey in Spain","volume":"11","author":"Robles","year":"2017","journal-title":"Diabetes Metab Syndr"},{"key":"R14-20260420","doi-asserted-by":"crossref","first-page":"3273","DOI":"10.1001\/jama.289.24.3273","article-title":"Renal insufficiency in the absence of albuminuria and retinopathy among adults with type 2 diabetes mellitus","volume":"289","author":"Kramer","year":"2003","journal-title":"JAMA"},{"key":"R15-20260420","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.2337\/dc19-2049","article-title":"The prognosis of patients with type 2 diabetes and nonalbuminuric diabetic kidney disease is not always poor: Implication of the effects of coexisting macrovascular complications (JDDM 54)","volume":"43","author":"Yokoyama","year":"2020","journal-title":"Diabetes Care"},{"key":"R16-20260420","doi-asserted-by":"crossref","first-page":"1886","DOI":"10.2337\/dc19-0349","article-title":"Progressive decline in estimated glomerular filtration rate in patients with diabetes after moderate loss in kidney function-even without albuminuria","volume":"42","author":"Vistisen","year":"2019","journal-title":"Diabetes Care"},{"key":"R17-20260420","doi-asserted-by":"crossref","first-page":"e3585","DOI":"10.1002\/dmrr.3585","article-title":"Type 2 diabetes albuminuric and non-albuminuric phenotypes have different morphological and functional ultrasound features of diabetic kidney disease","volume":"39","author":"Garofolo","year":"2023","journal-title":"Diabetes Metab Res Rev"},{"key":"R18-20260420","doi-asserted-by":"crossref","first-page":"1354","DOI":"10.1016\/j.ekir.2022.03.029","article-title":"Continuous glucose monitoring metrics in the assessment of glycemia in moderate-to-advanced CKD in diabetes","volume":"7","author":"Ling","year":"2022","journal-title":"Kidney Int Rep"},{"key":"R19-20260420","doi-asserted-by":"crossref","first-page":"110117","DOI":"10.1016\/j.diabres.2022.110117","article-title":"Glycaemic variability and progression of chronic kidney disease in people with diabetes and comorbid kidney disease: Retrospective cohort study","volume":"193","author":"Habte-Asres","year":"2022","journal-title":"Diabetes Res Clin Pract"},{"key":"R20-20260420","doi-asserted-by":"crossref","first-page":"1040319","DOI":"10.3389\/fpubh.2022.1040319","article-title":"The link between diabetic retinal and renal microvasculopathy is associated with dyslipidemia and upregulated circulating level of cytokines","volume":"10","author":"Chen","year":"2022","journal-title":"Front Public Health"},{"key":"R21-20260420","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1053\/j.ajkd.2021.11.011","article-title":"Nonalbuminuric diabetic kidney disease and risk of all-cause mortality and cardiovascular and kidney outcomes in type 2 diabetes: Findings from the Hong Kong Diabetes Biobank","volume":"80","author":"Jin","year":"2022","journal-title":"Am J Kidney Dis"},{"key":"R22-20260420","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1038\/s41581-021-00462-y","article-title":"Trajectories of kidney function in diabetes: A clinicopathological update","volume":"17","author":"Oshima","year":"2021","journal-title":"Nat Rev Nephrol"},{"key":"R23-20260420","doi-asserted-by":"crossref","first-page":"678","DOI":"10.3390\/jcm13030678","article-title":"Risk factors of chronic kidney disease progression: Between old and new concepts","volume":"13","author":"Mallamaci","year":"2024","journal-title":"J Clin Med"},{"key":"R24-20260420","doi-asserted-by":"crossref","first-page":"e000011","DOI":"10.1136\/bmjdrc-2013-000011","article-title":"Retinopathy and clinical outcomes in patients with type 2 diabetes mellitus, chronic kidney disease, and anemia","volume":"2","author":"Bello","year":"2014","journal-title":"BMJ Open Diabetes Res Care"},{"key":"R25-20260420","doi-asserted-by":"crossref","first-page":"e000275","DOI":"10.1136\/bmjdrc-2016-000275","article-title":"Evaluation of statin prescriptions in type 2 diabetes: India heart watch-2","volume":"4","author":"Gupta","year":"2016","journal-title":"BMJ Open Diabetes Res Care"},{"key":"R26-20260420","doi-asserted-by":"crossref","first-page":"S117","DOI":"10.1016\/j.kint.2023.10.018","article-title":"KDIGO 2024 clinical practice guideline for the evaluation and management of chronic kidney disease","volume":"105","year":"2024","journal-title":"Kidney Int"},{"key":"R27-20260420","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1186\/s13098-024-01514-6","article-title":"Simvastatin reduces chronic kidney disease and renal failure risk in type 2 diabetes patients: Post hoc ACCORD trial analysis","volume":"16","author":"Pu","year":"2024","journal-title":"Diabetol Metab Syndr"},{"key":"R28-20260420","doi-asserted-by":"crossref","first-page":"2975","DOI":"10.2337\/dc20-1588","article-title":"Glycemic control and the risk of acute kidney injury in patients with type 2 diabetes and chronic kidney disease: Parallel population-based cohort studies in U.S. and Swedish routine care","volume":"43","author":"Xu","year":"2020","journal-title":"Diabetes Care"}],"container-title":["Nigerian Postgraduate Medical Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.4103\/npmj.npmj_341_25","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T18:55:35Z","timestamp":1786647335000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/npmj.npmj_341_25"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":28,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.4103\/npmj.npmj_341_25","relation":{},"ISSN":["1117-1936","2468-6875"],"issn-type":[{"value":"1117-1936","type":"print"},{"value":"2468-6875","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"2025-07-04","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-09-05","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}